|
Eine Ebene nach oben |
Gruppiert nach:
Dokumententyp
| Veröffentlichungsdatum
Springe zu: Zeitschriftenartikel
Anzahl der Publikationen: 15
Zeitschriftenartikel
Brioli, Annamaria 
ORCID: https://orcid.org/0000-0002-4072-7592; Lomaia, Elza ORCID: https://orcid.org/0000-0003-3290-7961; Fabisch, Christian; Sacha, Tomasz ORCID: https://orcid.org/0000-0002-7207-6595; Klamova, Hana; Morozova, Elena; Golos, Aleksandra; Ernst, Philipp ORCID: https://orcid.org/0000-0001-5165-9874; Olsson-Stromberg, Ulla; Zackova, Daniela; Nicolini, Franck E.; Bao, Han; Castagnetti, Fausto ORCID: https://orcid.org/0000-0002-0602-2628; Patkowska, Elzbieta ORCID: https://orcid.org/0000-0001-8691-4310; Mayer, Jiri; Hirschbühl, Klaus ORCID: https://orcid.org/0000-0002-4847-7460; Podgornik, Helena ORCID: https://orcid.org/0000-0003-3752-2067; Paczkowska, Edyta ORCID: https://orcid.org/0000-0001-7052-9741; Parry, Anne; Ernst, Thomas ORCID: https://orcid.org/0000-0003-2147-489X; Voskanyan, Astghik; Szczepanek, Elzbieta; Saussele, Susanne ORCID: https://orcid.org/0000-0003-0357-5785; Franke, Georg-Nikolaus ORCID: https://orcid.org/0000-0001-8239-002X; Kiani, Alexander ORCID: https://orcid.org/0000-0002-2494-4087; Faber, Edgar; Krause, Stefan ORCID: https://orcid.org/0000-0002-5259-4651; Casado, Luis Felipe; Lewandowski, Krzysztof; Eder, Matthias; Anhut, Peter; Gil, Justyna; Südhoff, Thomas; Hebart, Holger ORCID: https://orcid.org/0000-0003-4536-9955; Heibl, Sonja; Pfirrmann, Markus ORCID: https://orcid.org/0000-0002-8948-0690; Hochhaus, Andreas und Lauseker, Michael ORCID: https://orcid.org/0000-0002-6662-7127
(2024):
Management and outcome of patients with chronic myeloid leukemia in blast phase in the tyrosine kinase inhibitor era – analysis of the European LeukemiaNet Blast Phase Registry.
In: Leukemia [Forthcoming]
ORCID: https://orcid.org/0000-0002-4072-7592; Lomaia, Elza ORCID: https://orcid.org/0000-0003-3290-7961; Fabisch, Christian; Sacha, Tomasz ORCID: https://orcid.org/0000-0002-7207-6595; Klamova, Hana; Morozova, Elena; Golos, Aleksandra; Ernst, Philipp ORCID: https://orcid.org/0000-0001-5165-9874; Olsson-Stromberg, Ulla; Zackova, Daniela; Nicolini, Franck E.; Bao, Han; Castagnetti, Fausto ORCID: https://orcid.org/0000-0002-0602-2628; Patkowska, Elzbieta ORCID: https://orcid.org/0000-0001-8691-4310; Mayer, Jiri; Hirschbühl, Klaus ORCID: https://orcid.org/0000-0002-4847-7460; Podgornik, Helena ORCID: https://orcid.org/0000-0003-3752-2067; Paczkowska, Edyta ORCID: https://orcid.org/0000-0001-7052-9741; Parry, Anne; Ernst, Thomas ORCID: https://orcid.org/0000-0003-2147-489X; Voskanyan, Astghik; Szczepanek, Elzbieta; Saussele, Susanne ORCID: https://orcid.org/0000-0003-0357-5785; Franke, Georg-Nikolaus ORCID: https://orcid.org/0000-0001-8239-002X; Kiani, Alexander ORCID: https://orcid.org/0000-0002-2494-4087; Faber, Edgar; Krause, Stefan ORCID: https://orcid.org/0000-0002-5259-4651; Casado, Luis Felipe; Lewandowski, Krzysztof; Eder, Matthias; Anhut, Peter; Gil, Justyna; Südhoff, Thomas; Hebart, Holger ORCID: https://orcid.org/0000-0003-4536-9955; Heibl, Sonja; Pfirrmann, Markus ORCID: https://orcid.org/0000-0002-8948-0690; Hochhaus, Andreas und Lauseker, Michael ORCID: https://orcid.org/0000-0002-6662-7127
(2024):
Management and outcome of patients with chronic myeloid leukemia in blast phase in the tyrosine kinase inhibitor era – analysis of the European LeukemiaNet Blast Phase Registry.
In: Leukemia [Forthcoming]
Isfort, Susanne ORCID: https://orcid.org/0000-0002-2855-561X; Manz, Kirsi ORCID: https://orcid.org/0000-0002-7740-4076; Teichmann, Lino L.; Crysandt, Martina; Burchert, Andreas; Hochhaus, Andreas; Saussele, Susanne; Kiani, Alexander; Göthert, Joachim R.; Illmer, Thomas; Schafhausen, Philippe; Al-Ali, Haifa Kathrin; Stegelmann, Frank; Hänel, Mathias; Pfeiffer, Tim; Giagounidis, Aristoteles; Franke, Georg-Nikolaus; Koschmieder, Steffen; Fabarius, Alice; Ernst, Thomas; Warnken-Uhlich, Mareille; Wolber, Uta; Kohn, Denise; Pfirrmann, Markus ORCID: https://orcid.org/0000-0002-8948-0690; Wolf, Dominik und Brümmendorf, Tim H.
(2023):
Step-in dosing of bosutinib in pts with chronic phase chronic myeloid leukemia (CML) after second-generation tyrosine kinase inhibitor (TKI) therapy: results of the Bosutinib Dose Optimization (BODO) Study.
In: Annals of Hematology, Bd. 102: S. 2741-2752
[PDF, 1MB]
ORCID: https://orcid.org/0000-0002-2855-561X; Manz, Kirsi ORCID: https://orcid.org/0000-0002-7740-4076; Teichmann, Lino L.; Crysandt, Martina; Burchert, Andreas; Hochhaus, Andreas; Saussele, Susanne; Kiani, Alexander; Göthert, Joachim R.; Illmer, Thomas; Schafhausen, Philippe; Al-Ali, Haifa Kathrin; Stegelmann, Frank; Hänel, Mathias; Pfeiffer, Tim; Giagounidis, Aristoteles; Franke, Georg-Nikolaus; Koschmieder, Steffen; Fabarius, Alice; Ernst, Thomas; Warnken-Uhlich, Mareille; Wolber, Uta; Kohn, Denise; Pfirrmann, Markus ORCID: https://orcid.org/0000-0002-8948-0690; Wolf, Dominik und Brümmendorf, Tim H.
(2023):
Step-in dosing of bosutinib in pts with chronic phase chronic myeloid leukemia (CML) after second-generation tyrosine kinase inhibitor (TKI) therapy: results of the Bosutinib Dose Optimization (BODO) Study.
In: Annals of Hematology, Bd. 102: S. 2741-2752
[PDF, 1MB]
Hofmann, Felix O. ORCID: https://orcid.org/0000-0002-6913-2429; Heinemann, Volker; D'Anastasi, Melvin; Gesenhues, Alena B.; Hesse, Nina; Weikersthal, Ludwig Fischer von; Decker, Thomas; Kiani, Alexander; Moehler, Markus; Kaiser, Florian; Heintges, Tobias; Kahl, Christoph; Kullmann, Frank; Scheithauer, Werner; Link, Hartmut; Modest, Dominik P.; Stintzing, Sebastian und Holch, Julian W.
(2022):
Standard diametric versus volumetric early tumor shrinkage as a predictor of survival in metastatic colorectal cancer: subgroup findings of the randomized, open-label phase III trial FIRE-3/AIO KRK-0306.
In: European Radiology, Bd. 33, Nr. 2: S. 1174-1184
[PDF, 2MB]
ORCID: https://orcid.org/0000-0002-6913-2429; Heinemann, Volker; D'Anastasi, Melvin; Gesenhues, Alena B.; Hesse, Nina; Weikersthal, Ludwig Fischer von; Decker, Thomas; Kiani, Alexander; Moehler, Markus; Kaiser, Florian; Heintges, Tobias; Kahl, Christoph; Kullmann, Frank; Scheithauer, Werner; Link, Hartmut; Modest, Dominik P.; Stintzing, Sebastian und Holch, Julian W.
(2022):
Standard diametric versus volumetric early tumor shrinkage as a predictor of survival in metastatic colorectal cancer: subgroup findings of the randomized, open-label phase III trial FIRE-3/AIO KRK-0306.
In: European Radiology, Bd. 33, Nr. 2: S. 1174-1184
[PDF, 2MB]
Fischer, Laura E. ORCID: https://orcid.org/0000-0001-8752-5827; Stintzing, Sebastian; Weikersthal, Ludwig Fischer von; Modest, Dominik P.; Decker, Thomas; Kiani, Alexander ORCID: https://orcid.org/0000-0002-2494-4087; Kaiser, Florian; Al-Batran, Salah-Eddin; Heintges, Tobias; Lerchenmüller, Christian; Kahl, Christoph; Seipelt, Gernot; Kullmann, Frank; Stauch, Martina; Scheithauer, Werner; Giessen-Jung, Clemens; Uhlig, Jens; Peuser, Bettina; Denzlinger, Claudio; Stahler, Arndt; Weiss, Lena; Heinrich, Kathrin; Held, Swantje; Jung, Andreas; Kirchner, Thomas und Heinemann, Volker
(2022):
Efficacy of FOLFIRI plus cetuximab vs FOLFIRI plus bevacizumab in 1st-line treatment of older patients with RAS wild-type metastatic colorectal cancer: an analysis of the randomised trial FIRE-3.
In: British Journal of Cancer, Bd. 127, Nr. 5: S. 836-843
[PDF, 788kB]
ORCID: https://orcid.org/0000-0001-8752-5827; Stintzing, Sebastian; Weikersthal, Ludwig Fischer von; Modest, Dominik P.; Decker, Thomas; Kiani, Alexander ORCID: https://orcid.org/0000-0002-2494-4087; Kaiser, Florian; Al-Batran, Salah-Eddin; Heintges, Tobias; Lerchenmüller, Christian; Kahl, Christoph; Seipelt, Gernot; Kullmann, Frank; Stauch, Martina; Scheithauer, Werner; Giessen-Jung, Clemens; Uhlig, Jens; Peuser, Bettina; Denzlinger, Claudio; Stahler, Arndt; Weiss, Lena; Heinrich, Kathrin; Held, Swantje; Jung, Andreas; Kirchner, Thomas und Heinemann, Volker
(2022):
Efficacy of FOLFIRI plus cetuximab vs FOLFIRI plus bevacizumab in 1st-line treatment of older patients with RAS wild-type metastatic colorectal cancer: an analysis of the randomised trial FIRE-3.
In: British Journal of Cancer, Bd. 127, Nr. 5: S. 836-843
[PDF, 788kB]
Liu, Lian; Erickson, Nicole Tonya; Ricard, Ingrid; Weikersthal, Ludwig Fischer von; Lerch, Markus M.; Decker, Thomas; Kiani, Alexander; Kaiser, Florian; Heintges, Tobias; Kahl, Christoph; Kullmann, Frank; Scheithauer, Werner; Link, Hartmut; Hoeffkes, Heinz-Gert; Moehler, Markus; Gesenhues, Alena Britta; Theurich, Sebastian; Michl, Marlies; Modest, Dominik P.; Alguel, Hana; Stintzing, Sebastian; Heinemann, Volker und Holch, Julian W.
(2021):
Early weight loss is an independent risk factor for shorter survival and increased side effects in patients with metastatic colorectal cancer undergoing first-line treatment within the randomized Phase III trial FIRE-3 (AIO KRK-0306).
In: International Journal of Cancer, Bd. 150, Nr. 1: S. 112-123
Stahler, Arndt; Stintzing, Sebastian; Einem, Jobst C. von; Westphalen, Christoph B.; Heinrich, Kathrin; Kraemer, Nicole; Michl, Marlies; Modest, Dominik P.; Fischer von Weikersthal, Ludwig; Decker, Thomas; Kiani, Alexander; Heintges, Tobias; Kahl, Christoph; Kullmann, Frank; Scheithauer, Werner; Moehler, Markus; Kaiser, Florian; Kirchner, Thomas; Jung, Andreas und Heinemann, Volker
(2020):
Single-nucleotide variants, tumour mutational burden and microsatellite instability in patients with metastatic colorectal cancer: Next-generation sequencing results of the FIRE-3 trial.
In: European Journal of Cancer, Bd. 137: S. 250-259
Heinemann, Volker; Fischer von Weikersthal, Ludwig; Decker, Thomas; Kiani, Alexander; Kaiser, Florian; Al-Batran, Salah-Edin; Heintges, Tobias; Lerchenmüller, Christoph; Kahl, Christoph; Seipelt, Gernot; Kullmann, Frank; Moehler, Markus; Scheithauer, Werner; Held, Swantje; Miller-Phillips, Lisa; Modest, Dominik Paul; Jung, Andreas; Kirchner, Thomas und Stintzing, Sebastian
(2020):
FOLFIRI plus cetuximab or bevacizumab for advanced colorectal cancer: final survival and per-protocol analysis of FIRE-3, a randomised clinical trial.
In: British Journal of Cancer, Bd. 124, Nr. 3: S. 587-594
Stahler, Arndt; Stintzing, Sebastian; Modest, Dominik P.; Ricard, Ingrid; Giessen-Jung, Clemens; Kapaun, Christine; Ivanova, Boryana; Kaiser, Florian; Fischer von Weikersthal, Ludwig; Moosmann, Nicolas; Schalhorn, Andreas; Stauch, Martina; Kiani, Alexander; Held, Swantje; Decker, Thomas; Moehler, Markus; Neumann, Jens; Kirchner, Thomas; Jung, Andreas und Heinemann, Volker
(2020):
Amphiregulin Expression Is a Predictive Biomarker for EGFR Inhibition in Metastatic Colorectal Cancer: Combined Analysis of Three Randomized Trials.
In: Clinical Cancer Research, Bd. 26, Nr. 24: S. 6559-6567
Saussele, Susanne; Haverkamp, Wilhelm; Lang, Fabian; Koschmieder, Steffen; Kiani, Alexander; Jentsch-Ullrich, Kathleen; Stegelmann, Frank; Pfeifer, Heike; La Rosee, Paul; Goekbuget, Nicola; Rieger, Christina; Waller, Cornelius F.; Franke, Georg-Nikolaus; le Coutre, Philipp; Kirchmair, Rudolf und Junghanss, Christian
(2020):
Ponatinib in the Treatment of Chronic Myeloid Leukemia and Philadelphia Chromosome-Positive Acute Leukemia: Recommendations of a German Expert Consensus Panel with Focus on Cardiovascular Management.
In: Acta Haematologica, Bd. 143, Nr. 3: S. 217-231
Rinaldetti, Sébastien; Pfirrmann, Markus; Manz, Kirsi ORCID: https://orcid.org/0000-0002-7740-4076; Guilhot, Joelle; Dietz, Christian; Panagiotidis, Panayiotidis; Spiess, Birgit; Seifarth, Wolfgang; Fabarius, Alice; Müller, Martin; Pagoni, Maria; Dimou, Maria; Dengler, Jolanta; Waller, Cornelius F.; Brümmendorf, Tim H.; Herbst, Regina; Burchert, Andreas; Janßen, Carsten; Goebeler, Maria Elisabeth; Jost, Philipp J.; Hanzel, Stefan; Schafhausen, Philippe; Prange-Krex, Gabriele; Illmer, Thomas; Janzen, Viktor; Klausmann, Martine; Eckert, Robert; Büschel, Gerd; Kiani, Alexander; Hofmann, Wolf-Karsten; Mahon, François-Xavier und Saussele, Susanne
(April 2018):
Effect of ABCG2, OCT1, and ABCB1(MDR1) Gene Expression on Treatment-Free Remission in a EURO-SKI Subtrial.
In: Clinical Lymphoma, Myeloma & Leukemia, Bd. 18, Nr. 4: S. 266-271
[PDF, 462kB]
ORCID: https://orcid.org/0000-0002-7740-4076; Guilhot, Joelle; Dietz, Christian; Panagiotidis, Panayiotidis; Spiess, Birgit; Seifarth, Wolfgang; Fabarius, Alice; Müller, Martin; Pagoni, Maria; Dimou, Maria; Dengler, Jolanta; Waller, Cornelius F.; Brümmendorf, Tim H.; Herbst, Regina; Burchert, Andreas; Janßen, Carsten; Goebeler, Maria Elisabeth; Jost, Philipp J.; Hanzel, Stefan; Schafhausen, Philippe; Prange-Krex, Gabriele; Illmer, Thomas; Janzen, Viktor; Klausmann, Martine; Eckert, Robert; Büschel, Gerd; Kiani, Alexander; Hofmann, Wolf-Karsten; Mahon, François-Xavier und Saussele, Susanne
(April 2018):
Effect of ABCG2, OCT1, and ABCB1(MDR1) Gene Expression on Treatment-Free Remission in a EURO-SKI Subtrial.
In: Clinical Lymphoma, Myeloma & Leukemia, Bd. 18, Nr. 4: S. 266-271
[PDF, 462kB]
Holch, Julian W.; Ricard, Ingrid; Stintzing, Sebastian; Fischer von Weikersthal, Ludwig; Decker, Thomas; Kiani, Alexander; Vehling-Kaiser, Ursula; Al-Batran, Salah; Heintges, Tobias; Lerchenmüller, Christian; Kahl, Christoph; Kullmann, Frank; Scheithauer, Werner; Scholz, Michael; Müller, Sebastian; Link, Hartmut; Rost, Andreas; Höffkes, Heinz-Gert; Moehler, Markus; Lindig, Reinhard Udo; Miller-Phillips, Lisa; Kirchner, Thomas; Jung, Andreas; Einem, Jobst C. von; Modest, Dominik Paul und Heinemann, Volker
(2018):
Relevance of liver-limited disease in metastatic colorectal cancer: Subgroup findings of the FIRE-3/AIO KRK0306 trial.
In: International Journal of Cancer, Bd. 142, Nr. 5: S. 1047-1055
Modest, Dominik P.; Stintzing, Sebastian; Fischer von Weikersthal, Ludwig; Decker, Thomas; Kiani, Alexander; Vehling-Kaiser, Ursula; Al-Batran, Salah-Eddin; Heintges, Tobias; Lerchenmüller, Christian; Kahl, Christoph; Seipelt, Gernot; Kullmann, Frank; Scheithauer, Werner; Kirchner, Thomas; Jung, Andreas; Stauch, Martina; Einem, Jobst Christian von; Möhler, Markus; Held, Swantje und Heinemann, Volker
(2017):
Relation of early tumor shrinkage (ETS) observed in first-line treatment to efficacy parameters of subsequent treatment in FIRE-3 (AIOKRK0306).
In: International Journal of Cancer, Bd. 140, Nr. 8: S. 1918-1925
Schoffer, Olaf; Schülein, Stefanie; Arand, Gerlinde; Arnholdt, Hans; Baaske, Dieter; Bargou, Ralf C.; Becker, Nikolaus; Beckmann, Matthias W.; Bodack, Yves; Böhme, Beatrix; Bozkurt, Tayfun; Breitsprecher, Regine; Buchali, Andre; Burger, Elke; Burger, Ulrike; Dommisch, Klaus; Elsner, Gudrun; Fernschild, Karin; Flintzer, Ulrike; Funke, Uwe; Gerken, Michael; Göbel, Hubert; Grobe, Norbert; Gumpp, Vera; Heinzerling, Lucie; Kempfer, Lana Raffaela; Kiani, Alexander; Klinkhammer-Schalke, Monika; Klöcking, Sabine; Kreibich, Ute; Knabner, Katrin; Kuhn, Peter; Lutze, Stine; Mäder, Uwe; Maisel, Tanja; Maschke, Jan; Middeke, Martin; Neubauer, Andreas; Niedostatek, Antje; Opazo-Saez, Anabelle; Peters, Christoph; Schell, Beatrice; Schenkirsch, Gerhard; Schmalenberg, Harald; Schmidt, Peter; Schneider, Constanze; Schubotz, Birgit; Seide, Anika; Strecker, Paul; Taubenheim, Sabine; Wackes, Matthias; Weiß, Steffen; Welke, Claudia; Werner, Carmen; Wittekind, Christian; Wulff, Jörg; Zettl, Heike und Klug, Stefanie J.
(2016):
Tumour stage distribution and survival of malignant melanoma in Germany 2002-2011.
In: BMC Cancer
16:936
[PDF, 976kB]
Modest, Dominik Paul; Stintzing, Sebastian; Fischer von Weikersthal, Ludwig; Sobrero, Alberto F.; Decker, Thomas; Kiani, Alexander; Vehling-Kaiser, Ursula; Al-Batran, Salah-Eddin; Heintges, Tobias; Seipelt, Gernot; Lerchenmüller, Christian A.; Kahl, Christoph; Kullmann, Frank; Stauch, Martina; Scheithauer, Werner; Held, Swantje; Moehler, Markus H.; Jung, Andreas; Kirchner, Thomas und Heinemann, Volker
(2016):
Time-course evaluation of survival and treatment in FIRE-3 (AIO KRK0306, first-line therapy of KRAS wild-type metastatic colorectal cancer with FOLFIRI plus cetuximab or bevacizumab).
In: Journal of Clinical Oncology, Bd. 34, Nr. 4
Stintzing, Sebastian; Modest, Dominik P.; Rossius, Lisa; Lerch, Markus M.; Fischer von Weikersthal, Ludwig; Decker, Thomas; Kiani, Alexander; Vehling-Kaiser, Ursula; Al-Batran, Salah-Eddin; Heintges, Tobias; Lerchenmüller, Christian; Kahl, Christoph; Seipelt, Gernot; Kullmann, Frank; Stauch, Martina; Scheithauer, Werner; Held, Swantje; Giessen-Jung, Clemens; Moehler, Markus; Jagenburg, Andreas; Kirchner, Thomas; Jung, Andreas und Heinemann, Volker
(2016):
FOLFIRI plus cetuximab versus FOLFIRI plus bevacizumab for metastatic colorectal cancer (FIRE-3): a post-hoc analysis of tumour dynamics in the final RAS wild-type subgroup of this randomised open-label phase 3 trial.
In: Lancet Oncology, Bd. 17, Nr. 10: S. 1426-1434